David Van Avermaete - 30 Apr 2024 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)

Role
Director
Signature
/s/ Thomas T. Higgins, Attorney-in-fact
Issuer symbol
NURO
Transactions as of
30 Apr 2024
Transactions value $
$0
Form type
4
Filing time
02 May 2024, 16:01:58 UTC
Previous filing
04 Aug 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NURO Common Stock Options Exercise $23,580 +5,396 +245% $4.37 7,601 30 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NURO Restricted Stock Unit Options Exercise -$23,580 -5,396 -100% $4.37 0 30 Apr 2024 Common Stock 5,396 $4.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon the vesting of restricted stock units referred to in footnote 2.
F2 On August 4, 2023, the reporting person was granted 43,165 restricted stock units prior to the reverse stock split of the Issuer's common stock at a ratio 1-for-8, effective as of November 21, 2023, which vested 100% on April 30, 2024.